DarioHealth Files Routine 8-K on Feb 22, 2024

Ticker: DRIO · Form: 8-K · Filed: Feb 22, 2024 · CIK: 1533998

Dariohealth CORP. 8-K Filing Summary
FieldDetail
CompanyDariohealth CORP. (DRIO)
Form Type8-K
Filed DateFeb 22, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K, disclosure

TL;DR

**DarioHealth filed a routine 8-K on Feb 22, 2024, with no new material news, just standard disclosures.**

AI Summary

DarioHealth Corp. filed an 8-K on February 22, 2024, disclosing information under Regulation FD and regarding Financial Statements and Exhibits. The filing indicates no specific new material events beyond the standard reporting requirements for these items, suggesting a routine disclosure. The company, incorporated in Delaware with IRS Employer Identification No. 45-2973162, maintains its business address at 122 W 57th St, #33B, New York, New York 10019.

Why It Matters

This filing is a standard regulatory disclosure, indicating the company is adhering to SEC reporting requirements, which is important for maintaining transparency with investors.

Risk Assessment

Risk Level: low — The filing is a routine 8-K with no indication of new material events or changes that would introduce significant risk.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by DarioHealth Corp.?

This 8-K filing by DarioHealth Corp. is a Current Report pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934, specifically disclosing information under Regulation FD and regarding Financial Statements and Exhibits, as of February 22, 2024.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 22, 2024.

What is DarioHealth Corp.'s state of incorporation and IRS Employer Identification Number?

DarioHealth Corp. is incorporated in Delaware and its IRS Employer Identification Number is 45-2973162.

What is the business address of DarioHealth Corp. as stated in the filing?

The business address of DarioHealth Corp. is 122 W 57th St, #33B, New York, New York 10019.

Does this 8-K filing indicate any significant new material events for DarioHealth Corp.?

No, the filing primarily lists 'Regulation FD Disclosure' and 'Financial Statements and Exhibits' as item information, which are standard reporting categories and do not inherently indicate new significant material events beyond routine disclosure.

Filing Stats: 410 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-02-22 16:05:57

Key Financial Figures

Filing Documents

01

Item 7.01 Regulation FD Disclosure. On February 22, 2024, DarioHealth Corp. posted to its website an updated investor presentation, a copy of which is attached hereto as Exhibit 99.1.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits 99.1 Investor presentation (furnished herewith) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 22, 2024 DARIOHEALTH CORP. By: /s/ Zvi Ben David Name: Zvi Ben David Title: Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing